Atlas Trials

Apatinib Versus Placebo as a Third Line Treatment in Patients With Advanced or Metastatic Gastric Cancer

Clinical trial NCT00970138 · COMPLETED

Trial details

NCT number
NCT00970138
Sponsor
Fudan University
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Gastric Carcinoma
Start date
2009-06-01
Primary completion
2010-10-01
Enrollment
141

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.